Methohexital-induced seizures during electroconvulsive therapy.

Area of Science:

• Anesthesiology
• Neurology
• Pediatric Medicine

Background:

• Methohexital is a widely used anesthetic for electroconvulsive therapy (ECT).
• Adult studies report rare instances of tonic-clonic seizures post-methohexital administration.
• Seizure occurrence in pediatric patients receiving methohexital for ECT has not been documented.

Observation:

• This case report details a 15-year-old female adolescent undergoing ECT.
• The patient received 60 mg of methohexital as part of her ECT procedure.
• She had a history of multiple prior bitemporal ECT sessions.

Findings:

• The adolescent experienced a generalized tonic-clonic seizure immediately following methohexital administration.
• This represents the first documented case of methohexital-induced seizure in a pediatric or adolescent population.
• The event occurred despite a history of prior ECT sessions without similar complications.

Implications:

• This finding suggests that methohexital may precipitate seizures in adolescents, a possibility not previously highlighted in medical literature.
• Clinicians should be aware of this potential adverse event when administering methohexital for ECT in pediatric and adolescent patients.
• Further research is warranted to understand the underlying mechanisms and prevalence of methohexital-induced seizures in younger populations.